BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $23.9 million in its third quarter. The Boston-based company said it had a loss of 29 cents per share.

Executed global exclusive development and commercialization license agreement with Novartis to advance VAV1-directed molecular glue degraders including MRT-6160 for immune-related conditions; $150M ...

The Ultimate Rodial Beauty Discovery Kit is a comprehensive set covering all your beauty needs, and is currently on sale for £57 - but be quick as the offer won't last long ...

There are a couple of fairly new banners hanging in Northwood High School’s gymnasium honoring the individual achievements ...

From UV lights to sticky paper, these 7 effective indoor mosquito traps will keep your home pest-free all summer long without ...

Dive into a fascinating reaction as super glue meets baking soda Watch as these everyday items create an unbreakable bond and transform right before your eyes This quick trick is surprisingly powerful ...

Discover a lesser-known super glue trick that takes repairs to the next level! By combining super glue with ash powder, you ...

Curiosity and fascination are two powerful indicators that this is the real deal, especially when the first rushes of ...

Created by scientists at Kyoto University in partnership with homebuilder Sumitomo Forestry, each side of the cubesat measures a mere 4 inches (about 10 centimeters). It’s made of honoki, a type of ...

Germany’s ruling coalition has long been standing on shaky ground, but the situation has become critical in recent weeks, with a break up more likely than ever.

As we approach election night why am I reminded of that scene from the movie Airplane! where Lloyd Bridges, playing a ...

Jeff Bell rounds Up Week 9 in the NFL and assesses where the league stands. The NFL has prided itself on parity. The World ...